| Field | Specification |
|---|---|
| Mfr No | |
| Activity | |
| Alternative Names | (2R,3R,5S)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolan-3-ol; 3-deoxyadenosine; NSC 63984 |
| Cas No. | |
| Form | White powder |
| Molecular Weight | |
| Product Type | |
| Purity | |
| Shipping | |
| SMILES | |
| Solubility | May be dissolved in DMSO (25 mg/ml) |
| Source | Synthetic |
| Storage |
Cordycepin (3′-deoxyadenosine) is a naturally occurring adenosine analog that lacks a hydroxyl group at the 3′ position of its ribose moiety. This structural modification allows Cordycepin to interfere with RNA synthesis, polyadenylation, and cellular signaling pathways, making it a versatile molecule in biomedical research. In neuroscience, Cordycepin has garnered attention for its neuroprotective and anti-inflammatory properties, particularly in the context of neurodegenerative diseases.
Cordycepin has been shown to inhibit poly(ADP-ribose) polymerase 1 (PARP1), a key enzyme involved in DNA repair and cell death pathways. Overactivation of PARP1 is associated with neuronal damage in conditions such as Alzheimer’s and Parkinson’s disease. By modulating PARP1 activity, Cordycepin may help preserve neuronal integrity and reduce oxidative stress-induced apoptosis.
Additionally, Cordycepin exhibits anti-inflammatory effects by downregulating pro-inflammatory cytokines and signaling pathways, contributing to a reduction in neuroinflammation—a hallmark of many neurodegenerative disorders. It has also demonstrated the ability to inhibit beta-amyloid-induced apoptosis in hippocampal neurons, suggesting a direct protective effect against Alzheimer’s-related toxicity.
Beyond its neurological applications, Cordycepin has shown anti-cancer and anti-obesity activities, highlighting its broad therapeutic potential. However, its emerging role in modulating neuronal survival, inflammation, and protein aggregation positions it as a promising candidate for further exploration in neurodegenerative disease research.
Classification: Not a hazardous substance or mixture.
Safety Phrases:
- S22 - Do not breathe dust.
- S24/25 - Avoid contact with skin and eyes.
- S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
Cordycepin (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-576)
Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.
- Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
- Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
- Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
- QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
- Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity
To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).
Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close
equivalents, or discuss custom synthesis with the right QC documentation (RUO).
2. A Kondrashov et al. RNA 2012 18:2236
3. J Yang et al. Biomed. Pharmacother. 2017 95:1777
4. H Song et al. Neurotoxicology 2018 68:73
5. Y Zhang et al. OncoTargets Ther. 2018 11:4479
6. Y Li et al. Curr. Pharm. Des. 2018 Aug. 20, epub